Cargando…

Incidence and Risk Factors for Antiplatelet Therapy–Related Bleeding Complications Among Elderly Patients After Coronary Stenting: A Multicenter Retrospective Observation

Purpose: To determine the incidence and risk factors of bleeding events as well as assess the performance of the PRECISE-DAPT score in elderly patients (≥75 years) who underwent percutaneous coronary intervention (PCI) and one-year dual antiplatelet therapy (DAPT). Methods: A total of 940 patients (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qian, Yanxia, Xu, Bing, Qian, Xiaodong, Cao, Lu, Cheng, Yujia, Liu, Xinjian, Bai, Song, Han, Zhijun, Wang, Junhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362353/ https://www.ncbi.nlm.nih.gov/pubmed/34393770 http://dx.doi.org/10.3389/fphar.2021.661619

Ejemplares similares

Performance of PRECISE-DAPT and Age–Bleeding–Organ Dysfunction Score for Predicting Bleeding Complication During Dual Antiplatelet Therapy in Chinese Elderly Patients
por: Dong, Liang, et al.
Publicado: (2022)

The stent in the high-bleeding risk patient: antiplatelet monotherapy?
por: Capranzano, Piera
Publicado: (2022)

A New Score for Predicting Acute Gastrointestinal Bleeding in Patients Administered Oral Antiplatelet Drugs
por: Lv, Meina, et al.
Publicado: (2021)

Gastroscopy-related adverse cardiac events and bleeding complications among patients treated with coronary stents and dual antiplatelet therapy
por: Egholm, Gro, et al.
Publicado: (2016)

Incidence and impact of antiplatelet therapy cessation among very older patients with stable coronary artery disease
por: Zou, Xiao, et al.
Publicado: (2023)

Long-term dual antiplatelet treatment and bleeding complications in diabetic patients treated with drug eluting stent implantation
por: Voudris, Vassilis, et al.
Publicado: (2014)

Incidence of bleeding in patients on different anticoagulants and antiplatelet therapies undergoing thoracentesis
por: Aljundi, Lamia, et al.
Publicado: (2021)

Monomeric CRP Aggravates Myocardial Injury After Myocardial Infarction by Polarizing the Macrophage to Pro-Inflammatory Phenotype Through JNK Signaling Pathway
por: Zha, Zhimin, et al.
Publicado: (2021)

Dabigatran Added to Dual Antiplatelet Therapy to Treat a Left Ventricular Thrombus in an 87 Year Old Patient With Myocardial Infarction and Very High Bleeding Risk
por: Noflatscher, Maria, et al.
Publicado: (2018)

Dual Antiplatelet Therapy (DAPT) versus No Antiplatelet Therapy and Incidence of Major Bleeding in Patients on Venoarterial Extracorporeal Membrane Oxygenation
por: Staudacher, Dawid L., et al.
Publicado: (2016)

The impact of dual antiplatelet therapy administration on the risk of bleeding complications during coronary artery bypass surgery
por: Nardi, Paolo, et al.
Publicado: (2021)

Antiplatelet Agents Inhibit the Generation of Platelet-Derived Microparticles
por: Giacomazzi, Alice, et al.
Publicado: (2016)

One-Month Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention With Zotarolimus-Eluting Stents in High-Bleeding-Risk Patients
por: Kandzari, David E., et al.
Publicado: (2020)

Risk Scores of Bleeding Complications in Patients on Dual Antiplatelet Therapy: How to Optimize Identification of Patients at Risk of Bleeding after Percutaneous Coronary Intervention
por: Pelliccia, Francesco, et al.
Publicado: (2022)

Antiplatelet and Antithrombotic Activity of a Traditional Medicine, Hwangryunhaedok-Tang
por: Kim, Kyungho, et al.
Publicado: (2019)

Antiplatelet Therapy in Atherothrombotic Diseases: Similarities and Differences Across Guidelines
por: Jourdi, Georges, et al.
Publicado: (2022)

Incidence, characteristics and risk factors of hypofibrinogenemia associated with tigecycline: A multicenter retrospective study in China
por: Leng, Bing, et al.
Publicado: (2022)

Is laparoscopic colorectal surgery with continuation of antiplatelet therapy safe without increasing bleeding complications?
por: Taguchi, Kazuhiro, et al.
Publicado: (2019)

Bleeding Complications in Anticoagulated and/or Antiplatelet-Treated Patients at the Dental Office: A Retrospective Study
por: Martínez-Moreno, Esther, et al.
Publicado: (2021)

Risk Factors for Severe Bleeding Complications in Glaucoma Surgery and the Role of Antiplatelet or Anticoagulant Agents
por: Lauermann, Peer, et al.
Publicado: (2022)

Molecular Mechanism of Puerarin Against Diabetes and its Complications
por: Bai, Yi-ling, et al.
Publicado: (2022)

Plant Alkaloids as Antiplatelet Agent: Drugs of the Future in the Light of Recent Developments
por: Ain, Qurrat-Ul-, et al.
Publicado: (2016)

Platelet-Derived Extracellular Vesicles as Target of Antiplatelet Agents. What Is the Evidence?
por: Taus, Francesco, et al.
Publicado: (2019)

Acute Coronary Syndrome, Antiplatelet Therapy, and Bleeding: A Clinical Perspective
por: Tersalvi, Gregorio, et al.
Publicado: (2020)

Stent thrombosis and optimal duration of dual antiplatelet therapy after coronary stenting in contemporary practice
por: Cho, Min Soo, et al.
Publicado: (2017)

Anticoagulants/antiplatelets: Bleeding: 14 case reports
Publicado: (2020)

Plasma apixaban levels in Chinese patients with chronic kidney disease—Relationship with renal function and bleeding complications
por: Sin, Chun-fung, et al.
Publicado: (2022)

Non-Persistence With Antiplatelet Medications Among Older Patients With Peripheral Arterial Disease
por: Wawruch, Martin, et al.
Publicado: (2021)

Antiplatelet therapy for elderly patients with Acute Coronary Syndromes
por: Savonitto, Stefano, et al.
Publicado: (2018)

One‐Month Dual Antiplatelet Therapy After Bioresorbable Polymer Everolimus‐Eluting Stents in High Bleeding Risk Patients
por: Pivato, Carlo A., et al.
Publicado: (2022)

Comparative efficacy and safety of antiplatelet or anticoagulant therapy in patients with chronic coronary syndromes after percutaneous coronary intervention: A network meta-analysis of randomized controlled trials
por: Lin, Yaowang, et al.
Publicado: (2022)

Phospholipase Cγ2 Signaling Cascade Contribute to the Antiplatelet Effect of Notoginsenoside Fc
por: Liu, Yingqiu, et al.
Publicado: (2018)

Antiplatelet Agents Have a Distinct Efficacy on Platelet Aggregation Induced by Infectious Bacteria
por: Hannachi, Nadji, et al.
Publicado: (2020)

Impact of bleeding during dual antiplatelet therapy in patients with coronary artery disease
por: Tung, Ying-Chang, et al.
Publicado: (2020)

Risk of gastrointestinal bleeding and cardiovascular events due to NSAIDs in the diabetic elderly population
por: Kim, Jungmee, et al.
Publicado: (2015)

Standard vs. Modified Antiplatelet Therapy Based on Thromboelastography With Platelet Mapping for Preventing Bleeding Events in Patients Undergoing Stent-Assisted Coil for a Ruptured Intracranial Aneurysm
por: Li, Yuanshu, et al.
Publicado: (2021)

Abbreviated Antiplatelet Therapy in Patients at High Bleeding Risk With or Without Oral Anticoagulant Therapy After Coronary Stenting: An Open-Label, Randomized, Controlled Trial
por: Smits, Pieter C., et al.
Publicado: (2021)

Plasma levels of platelet-enriched microRNAs change during antiplatelet therapy in healthy subjects
por: Krammer, Teresa L., et al.
Publicado: (2022)

Post-ERCP Bleeding in the Era of Multiple Antiplatelet Agents
por: Oh, Hyoung-Chul, et al.
Publicado: (2018)

Genetic testing in antiplatelet therapy – not effective for perioperative bleeding
por: Kuliczkowski, Wiktor
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_kovvolhvina7u48gsh9lkdua5s